December, 2010

Novel combination of two existing therapeutics shows promising activity in patients with advanced liver cancer 

An Interview with Prof Pierce Chow and Dr Choo Su Pin on AHCC05 Study: Phase I/II Study of SIR-Spheres plus Sorafenib (Chemo-Radiotherapy) as first line treatment in patients with non-resectable primary hepatocellular carcinoma. 

By Medical Grapevine >> Read the AHCC05 article